Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin-diazepam interaction.

Andrea Murphy1, Kerry Wilbur

  • 1School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada.

The Annals of Pharmacotherapy
|April 24, 2003
PubMed
Summary

Concurrent use of diazepam may increase phenytoin levels, leading to toxicity. This case highlights a potential drug interaction where diazepam altered phenytoin metabolism, causing adverse neurologic effects in a patient with epilepsy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Student Interprofessional Collaboration Experiences in Community Pharmacy.

American journal of pharmaceutical education·2026
Same author

How pharmacy education and practice cultivate researchers: the Canadian experience.

The International journal of pharmacy practice·2026
Same author

Comprehensive Geriatric Assessment by Primary Care Pharmacists.

Journal of applied gerontology : the official journal of the Southern Gerontological Society·2025
Same author

Patients and Community Members as Equal Partners in Curriculum Decision-Making.

The clinical teacher·2025
Same author

Implementation and acceptance of pharmacists' prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP).

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same author

Feasibility and acceptability of the Community Outpatient Psychotherapy Engagement Service for Self-harm (COPESS): randomised controlled trial.

BJPsych open·2025

Area of Science:

  • Clinical Pharmacology
  • Neuropharmacology
  • Drug Interactions

Background:

  • Phenytoin is a widely used antiepileptic drug with a narrow therapeutic index.
  • Drug interactions can significantly alter phenytoin serum concentrations and efficacy.
  • The metabolism of phenytoin involves hepatic cytochrome P450 enzymes, particularly CYP2C9 and CYP2C19.

Observation:

  • A patient with epilepsy presented with symptoms of phenytoin toxicity, including headache, nystagmus, diplopia, and ataxia.
  • The patient was concurrently prescribed diazepam and amoxicillin shortly before symptom onset.
  • Serum phenytoin concentration was significantly elevated (37 micro g/mL) compared to a previous measurement (8 micro g/L).

Findings:

  • Discontinuation of both phenytoin and diazepam led to the resolution of neurologic symptoms.
  • The Naranjo probability scale indicated a probable relationship between the observed adverse effects and the coadministration of phenytoin and diazepam.
  • Diazepam, metabolized by CYP2C19, may act as an alternate substrate, potentially inhibiting phenytoin's elimination via the same isoenzyme.

Implications:

  • This case suggests that diazepam can potentially increase serum phenytoin concentrations, leading to toxicity.
  • Clinicians should be aware of this potential interaction, especially when initiating diazepam in patients on phenytoin therapy.
  • The mechanism may involve diazepam acting as an alternate substrate for CYP2C19, affecting phenytoin metabolism through an underrecognized pathway.

Related Experiment Videos